IMMUNOGEN INC 4
4 · IMMUNOGEN INC · Filed Jan 23, 2014
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Morris Charles Q
Executive VP & CDO
Transactions
- Sale
Common Stock
2014-01-21$17.00/sh−5,535$94,095→ 37,500 total - Exercise/Conversion
Common Stock
2014-01-22$11.93/sh+1,603$19,124→ 39,103 total - Exercise/Conversion
Stock Option (right to buy)
2014-01-21$11.93/sh−5,535$66,033→ 194,465 totalExercise: $11.93From: 2013-11-26Exp: 2022-11-26→ Common Stock (5,535 underlying) - Exercise/Conversion
Common Stock
2014-01-21$11.93/sh+5,535$66,033→ 43,035 total - Sale
Common Stock
2014-01-22$17.00/sh−1,603$27,257→ 37,500 total - Exercise/Conversion
Stock Option (right to buy)
2014-01-22$11.93/sh−1,603$19,124→ 192,862 totalExercise: $11.93From: 2013-11-26Exp: 2022-11-26→ Common Stock (1,603 underlying)
Footnotes (3)
- [F1]Weighted average price of shares sold.
- [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on August 29, 2013.
- [F3]Exercisable as to 50,000 shares commencing on November 26, 2013, 50,000 shares commencing on November 26, 2014, 50,000 shares commencing on November 26, 2015, and 50,000 shares commencing on November 26, 2016.